Tin tức & Cập nhật
Xem bài viết Sản phụ khoa
Xem
Chỉ hiển thị Multimedia

Neoadjuvant olaparib feasible in BRCA-mutated ovarian cancer
23 May 2023
bởiElvira Manzano
Neoadjuvant treatment with the PARP* inhibitor olaparib yielded encouraging outcomes in patients with BRCA-mutated ovarian cancer, with all participants completing two cycles of therapy followed by surgery in the NOW trial presented at SGO 2023.
23 May 2023

In-utero exposure to poor air quality a risk factor for childhood ADHD
20 May 2023
bởiJairia Dela Cruz
Children born to mothers who were exposed to polluted air while pregnant are at increased risk of childhood attention-deficit hyperactivity disorder (ADHD), according to a study presented at PAS 2023.
20 May 2023

Toripalimab plus bevacizumab, SoC demonstrates promising efficacy for cervical cancer
15 May 2023
bởiAudrey Abella
Preliminary results of a single-arm, open-label, phase II trial demonstrated the efficacy of a combination regimen comprising toripalimab, bevacizumab, and platinum-based chemotherapy for women with refractory, recurrent, or metastatic cervical cancer.
15 May 2023






